Antibacterial and Anti-Inflammatory Effects of Novel Peptide Toxin from the Spider Pardosa astrigera

The prevalence of antibiotic-resistant bacteria has become an immediate threat to public health. Antimicrobial peptides are attracting attention as a new source of antibiotics due to their ability to prevent drug-resistances with fewer side effects. Spider venom is composed of various bioactive substances with multiple functionalities such as antimicrobial and anti-inflammatory effects. Here, RNA sequencing was conducted on the venom gland of the spider Pardosa astrigera, and a potential toxin peptide with antibacterial properties was selected via homology and in silico analysis. A novel toxin, Lycotoxin-Pa4a, inhibited both gram-negative and gram-positive bacteria by disrupting the outer and bacterial cytoplasmic membrane. Moreover, the peptide downregulated the expression of pro-inflammatory mediators while upregulating the level of anti-inflammatory cytokine by inactivating mitogen-activated protein kinase signaling in a lipopolysaccharide-stimulated murine macrophage cell line. In this research, we identified a novel peptide toxin, Lycotoxin-pa4a, with antibacterial and anti-inflammatory properties, suggesting its potential for the development of a new antibiotics, as well as offering insights into the utilization of biological resources.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:9

Enthalten in:

Antibiotics (Basel, Switzerland) - 9(2020), 7 vom: 19. Juli

Sprache:

Englisch

Beteiligte Personen:

Shin, Min Kyoung [VerfasserIn]
Hwang, In-Wook [VerfasserIn]
Kim, Yunkyung [VerfasserIn]
Kim, Seung Tae [VerfasserIn]
Jang, Wonhee [VerfasserIn]
Lee, Seungki [VerfasserIn]
Bang, Woo Young [VerfasserIn]
Bae, Chang-Hwan [VerfasserIn]
Sung, Jung-Suk [VerfasserIn]

Links:

Volltext

Themen:

Anti-inflammation
Antibacterial peptide
In silico analysis
Journal Article
Pardosa astrigera
Spider venom gland
Transcriptome

Anmerkungen:

Date Revised 28.09.2020

published: Electronic

Citation Status PubMed-not-MEDLINE

doi:

10.3390/antibiotics9070422

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM312836090